Skip to content

Organon OGN Change in Inventories

Change in Inventories at other companies

Pfizer logo
PfizerPFE
-$140.25M-166%
Amgen logo
AmgenAMGN
-$18M+93.8%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$11.5M-22.4%
Biogen logo
BiogenBIIB
-$116.2M-87.4%
AbbVie logo
AbbVieABBV
$184M+18.7%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$54.96M+314%

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's change in inventories?
Organon (OGN) reported change in inventories of $9M in Q1 2026.
How has Organon's change in inventories changed year-over-year?
Organon's change in inventories increased by 400.0% year-over-year, from -$3M to $9M.
What is the long-term trend for Organon's change in inventories?
Over 3 years (2021 to 2024), Organon's change in inventories has grown at a -1.7% compound annual growth rate (CAGR), from $138M to $131M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.